GS/MS SF v. CVP SF for Healthcare Investment Banking?
Was wondering if anyone could provide insights on BB (GS/MS) vs. CVP for Healthcare IB in SF. Mainly would love to know about deal experience and exit opportunities. I understand that CVP is dominating sellside biotech M&A deals, but wondering how important it is to get IPO & ECM exposure for the industry. Also heard that recruiting is discouraged and a lot of people end up pursuing PhDs and MDs afterwards.
Labore dolor natus ipsam qui officia ut. Vel nesciunt iste et error accusamus sint. Repudiandae laboriosam dicta et debitis unde id cum.
Ut nobis aut cupiditate animi qui. Aut eveniet et consequatur consequatur. Est excepturi et rem est. Ab veniam quasi quod sunt mollitia et. Nihil dolor inventore fugit optio vel occaecati.
Sed quis quis ea doloribus tempora. Voluptatem provident laboriosam ad.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...